Physician profile
Paul D Sponseller
NPI 1518994037
$957,718.24
in general payments reported to CMS, 2019-2025
12 companies · $31K in 2025
The $31K reported for 2025 was more than what 93% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $357K · 2020: $286K · 2021: $155K · 2022: $58K · 2023: $46K · 2024: $25K · 2025: $31K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $74K · Consulting Fee: $22K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $4,900 · Food and Beverage: $727 · Travel and Lodging: $383.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $74,030.72 |
| Consulting Fee | $21,905.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $4,900.00 |
| Food and Beverage | $726.54 |
| Travel and Lodging | $383.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Products, INC. | $649,020.12 | 2019-2021 | |
| Globus Medical, INC. | $203,337.29 | 2019-2025 | Reflect/Reflect Hde, Reflect, Marvel Growing Rod |
| Medical Device Business Services, INC. | $63,433.79 | 2019-2023 | Expedium |
| Orthopediatrics Corp. | $15,716.05 | 2019-2025 | |
| Nuvasive, INC. | $12,226.88 | 2019-2023 | |
| Alexion Pharmaceuticals, INC. | $7,380.00 | 2023 | |
| Pacira Pharmaceuticals Incorporated | $5,760.00 | 2020 | |
| Zimvie INC. | $508.54 | 2023 | |
| Smith+Nephew, INC. | $120.59 | 2025 | Evos, Maverick, Trigen Intertan |
| Medtronic USA, INC. | $105.33 | 2019 | |
| Stryker Corporation | $90.86 | 2020 | |
| Ipsen Biopharmaceuticals, INC | $18.79 | 2025 | Dysport |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Sponseller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.